. [O2–14–05]: Preclinical Characterization of an Antibody [LY3303560] Targeting Aggregated Tau. Alzheimer's & Dementia, 1 July 2017

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Zagotenemab